Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Compounded semaglutide, which contains the same active ingredient as Ozempic and Wegovy, is available from many telehealth companies and compounding pharmacies. It not FDA-approved or subject to ...

The drugmaker has been looking to diversify its lineup for years. For one, semaglutide, the active ingredient in Wegovy, is being investigated in other areas with high unmet needs. Perhaps the ...

Wegovy (semaglutide) has become a social media sensation as a weight-loss treatment after being name-checked by numerous celebrities, driving huge demand around the world and stretching Novo ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been ...

A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans. © 2024 Fortune Media IP Limited. All Rights ...

In the UK, the first patients to receive Wegovy from the NHS, a medication containing semaglutide that is approved for weight loss, began taking the jabs last year. However, the rollout has been slow, ...

Now, a new study finds that Ozempic, along with similar drugs such as Wegovy, has had a broad “economic and societal impact” because of “noticeable shifts in dietary behavior.” The study ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.